» Articles » PMID: 3886702

Relationship Between Insulin-mediated Glucose Disposal and Lipid Metabolism in Man

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1985 Apr 1
PMID 3886702
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

To assess the possible effects of lipid metabolism on insulin-mediated glucose disposal, 18 nondiabetic Pima Indian women (age 18-35 yr) were studied using 1-14C-palmitate infusion to measure free fatty acid turnover rate followed by a euglycemic clamp (clamp) to measure in vivo insulin-mediated glucose disposal (M). Indirect calorimetry was performed in the basal state and during the clamp. This was used to assess glucose oxidation rate, lipid oxidation rate, and to calculate nonoxidative glucose disposal (storage). Basal and clamp lipid oxidation rate correlated with basal plasma free fatty acid concentration (r = 0.81, P less than or equal to 0.0001, r = 0.67, P less than 0.003, respectively). The fall in lipid oxidation was highly correlated with the increase in glucose oxidation during the insulin infusion (r = 0.96, P less than or equal to 0.0001). The clamp lipid oxidation rate negatively correlated with the glucose oxidation rate (r = -0.85, P less than 0.0001) and with the M value (r = -0.60, P less than 0.01) but was not correlated with the clamp glucose storage (r = -0.2, P = 0.4). On the other hand, glucose storage appeared to make a greater contribution to the difference in M value between the upper and lower extremes of M than did glucose oxidation, as evidenced by an increase in glucose storage of 0.59 mg/kg fat-free mass times minute per 1 mg/kg fat-free mass times minute increase in glucose disposal. The M value was negatively correlated with obesity as measured by percent body fat (r = -0.64, P less than 0.004), but neither basal free fatty acid concentration, basal free fatty acid turnover, basal lipid oxidation, nor clamp lipid oxidation correlated with percent body fat. We conclude that an interaction of lipid and glucose metabolism in a glucose fatty acid cycle, as proposed by Randle et al. (1), may be operative in the regulation of glucose oxidation in man. The disposal of glucose however has two components. The storage component does not appear to be associated with lipid oxidation in the way that the oxidative component is and may be regulated by a different mechanism. Since the results show that the glucose storage component plays a significant role in distinguishing between those with low and high M values, we suggest that the glucose fatty acid cycle can, at best, only partially explain impaired in vivo insulin-mediated glucose disposal. Furthermore, the data suggest that the impact of obesity on in vivo insulin resistance appears to be mediated by factors other than changes in lipid availability or metabolism.

Citing Articles

Exome Sequencing Identifies A Nonsense Variant in DAO Associated With Reduced Energy Expenditure in American Indians.

Piaggi P, Koroglu C, Nair A, Sutherland J, Muller Y, Kumar P J Clin Endocrinol Metab. 2020; 105(11).

PMID: 32818236 PMC: 7501742. DOI: 10.1210/clinem/dgaa548.


Impaired Metabolic Flexibility to High-Fat Overfeeding Predicts Future Weight Gain in Healthy Adults.

Begaye B, Vinales K, Hollstein T, Ando T, Walter M, Bogardus C Diabetes. 2019; 69(2):181-192.

PMID: 31712321 PMC: 6971489. DOI: 10.2337/db19-0719.


Antilipolytic and antilipogenic effects of the CPT-1b inhibitor oxfenicine in the white adipose tissue of rats.

Sepa-Kishi D, Wu M, Uthayakumar A, Mohasses A, Ceddia R Am J Physiol Regul Integr Comp Physiol. 2016; 311(4):R779-R787.

PMID: 27558315 PMC: 5142162. DOI: 10.1152/ajpregu.00243.2016.


Subchronic sleep restriction causes tissue-specific insulin resistance.

Rao M, Neylan T, Grunfeld C, Mulligan K, Schambelan M, Schwarz J J Clin Endocrinol Metab. 2015; 100(4):1664-71.

PMID: 25658017 PMC: 4399283. DOI: 10.1210/jc.2014-3911.


Fasting hyperglycemia predicts lower rates of weight gain by increased energy expenditure and fat oxidation rate.

Piaggi P, Thearle M, Bogardus C, Krakoff J J Clin Endocrinol Metab. 2015; 100(3):1078-87.

PMID: 25559400 PMC: 4333033. DOI: 10.1210/jc.2014-3582.


References
1.
Verdonk C, Rizza R, Gerich J . Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes. 1981; 30(6):535-7. DOI: 10.2337/diab.30.6.535. View

2.
Hagenfeldt L, Wennlung A, FELIG P, Wahren J . Turnover and splanchnic metabolism of free fatty acids in hyperthyroid patients. J Clin Invest. 1981; 67(6):1672-7. PMC: 370743. DOI: 10.1172/jci110204. View

3.
DeFronzo R, Jacot E, Jequier E, MAEDER E, Wahren J, Felber J . The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 1981; 30(12):1000-7. DOI: 10.2337/diab.30.12.1000. View

4.
Mosora F, Lacroix M, Luyckx A, Pallikarakis N, Pirnay F, Krzentowski G . Glucose oxidation in relation to the size of the oral glucose loading dose. Metabolism. 1981; 30(12):1143-9. DOI: 10.1016/0026-0495(81)90033-0. View

5.
Rousselle J, Buckert A, Pahud P, Jequier E, Felber J . Relationship between glucose oxidation and glucose tolerance in man. Metabolism. 1982; 31(9):866-70. DOI: 10.1016/0026-0495(82)90174-3. View